Free Trial

Sagimet Biosciences (SGMT) SEC Filings & 10K Form

Sagimet Biosciences logo
$4.39 +0.12 (+2.81%)
Closing price 01/17/2025 04:00 PM Eastern
Extended Trading
$4.56 +0.17 (+3.87%)
As of 08:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sagimet Biosciences SEC Filings

DateFilerForm TypeView
01/02/2025
7:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:55 PM
Point72 Asset Management, L.P. (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:27 PM
BAKER BROS. ADVISORS LP (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
11/14/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
11:15 PM
Sagimet Biosciences (Filer)
Form EFFECT
08/16/2024
3:53 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:27 PM
Sagimet Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/14/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
7:06 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:05 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:24 PM
Kemble George (Reporting)
Sagimet Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:05 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:05 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:06 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:26 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:07 AM
Sagimet Biosciences (Filer)
Form 8-K/A
06/06/2024
5:03 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
6:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
7:06 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
5:16 AM
Sagimet Biosciences (Filer)
Form DEF 14A
04/18/2024
5:19 AM
Sagimet Biosciences (Filer)
Form DEFA14A
04/18/2024
5:21 AM
Sagimet Biosciences (Filer)
Form ARS
04/03/2024
7:15 PM
Sagimet Biosciences (Issuer)
Walbert Timothy P (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
7:17 PM
Hoelscher Paul W. (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:19 PM
Sagimet Biosciences (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:13 PM
Hoelscher Paul W. (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2024
3:08 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
6:00 AM
Sagimet Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2024
5:37 AM
Sagimet Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
5:19 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
02/14/2024
5:10 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/14/2024
5:20 AM
KPCB PANDEMIC & BIO DEFENSE FUND LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/09/2024
8:49 AM
FMR LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
02/05/2024
3:34 PM
Point72 Asset Management, L.P. (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/02/2024
3:36 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:55 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
2025: Crypto Opportunities You Can’t Afford to Miss (Ad)

Cryptocurrencies are once again gaining incredible momentum, and savvy investors are positioning themselves to capitalize on this surge in 2025. The question is—will you be among them? With groundbreaking advancements and increasing institutional adoption on the horizon, there's never been a better time to explore the potential gains in crypto. What’s Fueling the Crypto Comeback?

Get our comprehensive guide, Navigating the Future: Cryptos to Watch in 2025
01/31/2024
3:56 PM
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:57 PM
BASKETT FOREST (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:59 PM
KERINS PATRICK J (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:00 PM
Sagimet Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:05 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
11:15 PM
Sagimet Biosciences (Filer)
Form EFFECT
01/24/2024
5:08 AM
Sagimet Biosciences (Filer)
Form S-1/A
01/24/2024
5:10 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
4:31 PM
Sagimet Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/22/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SGMT) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners